PEGASYS
PHARMAAND GMBH
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PEGASYS in Canada?
Yes. PEGASYS 180MCG has an active shortage reported to Health Canada (last updated September 15, 2026).
Why is PEGASYS not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PEGASYS be available again?
The manufacturer's estimated resolution date is September 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PEGASYS
HOFFMANN-LA ROCHE LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-09-30
~2 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02248077
Strength
180MCG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
PEGINTERFERON ALFA-2A
Tier
Tier 3 — Critical
Last Updated
2026-09-15
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
PEGASYS has 2 shortage/discontinuation reports on file — this is one of them.